Bladder cancer treatment may be on the brink of a revolutionary transformation, thanks to a groundbreaking biomimetic drug delivery platform inspired by gecko feet. Soft dendritic particles (SDPs) offer a promising solution to the challenges of poor drug retention and limited therapeutic effectiveness in intravesical drug delivery. Coated with chitosan for enhanced adherence to bladder tissue, these SDPs mimic the adhesive properties of gecko feet, allowing for longer drug retention and controlled release. The innovative fluid flow templating method used to create SDPs from biodegradable poly(lactic-co-glycolic acid) (PLGA) sets the stage for more effective, low-toxicity bladder cancer therapies. By delivering commonly used chemotherapy drugs like gemcitabine, docetaxel, and methotrexate, SDPs have demonstrated significant improvements in cancer cell killing and tumor reduction in both lab experiments and mouse models. With the potential to trigger a strong immune response while minimizing toxicity, this nature-inspired nanomedicine holds promise for revolutionizing the landscape of bladder and epithelial cancer treatments.
Read more from emjreviews.com